Synthesis and Characterization of Cefditoren Capped Silver Nanoparticles and Their Antimicrobial and Catalytic Degradation of Ibuprofen
- 8 Downloads
While manufacturing silver nanoparticles (Ag-NPs) by green chemical rout, here we presented a naive, bottom-up and green rout for the production of Ag-NPs by successfully employed for catalytic degradation of ibuprofen drug. The Cefditoren derived silver nanoparticles were optimized by Ultra Violet–Visible spectroscopy, X-ray diffraction, Fourier transform infrared spectroscopy and high-resolution transmission electron microscope analysis. This work has shown that a comprehensive degradation of ibuprofen of about ~ 99.9% was attained in little reaction time (60 s) by nimble Cef-Ag-NPs. The precision was achieved in percent degradation of ibuprofen by altering and adjusting the reaction period, quantity, and concentration of catalyst. The calculated rate constant (K) value for ibuprofen catalytic degradation was attained in 8 × 10−2 S−1 by plotting in concentration (C) versus time (s). The bactericidal potency of fabricated Cef-Ag-NPs was also assessed for the preferred Gram-positive Staphylococcus aureus (S. aureus) and Streptococcus pyogenes (S. pyogens) and Gram-negative Escherichia coli (E. coli) and Salmonella typhimurium (S. typhimurium) bacterial species. The outcomes were inveterate that common antibiotic in amalgamation with silver nanoparticles had strong and drastic antibacterial effects as compared to individually treated antibiotic and silver ions. On behalf of these consequences, it was realized that concerning Cef-Ag-NPs would serve as fast, economic, and less conventional candidates for other harmful and antibiotic-resistant pathogens.
KeywordsGreen synthesis Cef-Ag-NPs Ibuprofen Catalytic activity Antibacterial efficacy Bacterial pathogens
Cefditoren derived silver nanoparticles
- UV Vis
Ultra Violet–Visible spectroscopy
Fourier transform infrared spectroscopy
High-resolution transmission electron microscopy
- S. aureus
- S. pyogens
- E. coli
- S. typhimurium
Nonsteroidal anti-inflammatory drugs
The authors would like to thank Dr. Ghulam Shabir, Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan for giving us bacterial strains and the necessary facilities.
YJ, GMQ and MS designed and performed the experiments. MS and RAK performed the measurements. KD, YJ, MAG and QS analyzed the measurement data. MO and MS finalized the manuscript. All authors read and approved the final manuscript.
The study was supported by a departmental research Grant (No. 00129865).
Compliance with Ethical Standards
Conflict of interest
The authors declare that they have no competing interests.
Availability of data and materials
All data supporting the conclusions of this article are included in the article.
- 7.M. Barbagallo and P. Sacerdote (2019). Minerva Pediatr. 71, 82.Google Scholar
- 14.A. Shetty and G. Gupta, in Int. Conf. Sustain. Waste Manag. Through Des. (Springer, 2018), pp. 586–595.Google Scholar
- 15.N. Jain, P. Bhosale, V. Tale, R. Henry, and J. Pawar (2019). Eurasian J. Biosci. 13, 27.Google Scholar
- 34.Y. Junejo and A. Baykal (2013). Cent. Eur. J. Chem 11, 1527.Google Scholar
- 36.L. C. L. de Abreu, V. Todaro, P. C. Sathler, L. C. R. P. da Silva, F. A. do Carmo, C. M. Costa, H. K. Toma, H. C. Castro, C. R. Rodrigues, V. P. de Sousa, and L. M. Cabral (2016). AAPS PharmSciTech. 17, 1421.Google Scholar
- 39.S. K. R. Namasivayam, S. Ganesh, and Avimanyu (2011). Int J Med Res. 1, 130.Google Scholar
- 41.B. Sadeghi, M. Jamali, S. Kia, and S. Ghafari (2010). Int. J. Nano Dimens. 1, 119.Google Scholar
- 43.T. Leisner, A. Panas, A. Comouth, H. Saathoff, T. Leisner, M. Al-rawi, M. Simon, G. Seemann, O. Dössel, S. Mülhopt, H. Paur, S. Fritsch-decker, C. Weiss, and S. Diabaté (2016). Beilstein J. Nanotechnol. 5, 1590.Google Scholar